Genomic alterations in lung adenocarcinoma S Devarakonda, D Morgensztern, R Govindan The lancet oncology 16 (7), e342-e351, 2015 | 421 | 2015 |
MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate AS Ireland, AM Micinski, DW Kastner, B Guo, SJ Wait, KB Spainhower, ... Cancer cell 38 (1), 60-78. e12, 2020 | 385 | 2020 |
Tumor mutation burden as a biomarker in resected non–small-cell lung cancer S Devarakonda, F Rotolo, MS Tsao, I Lanc, E Brambilla, A Masood, ... Journal of Clinical Oncology 36 (30), 2995-3006, 2018 | 249 | 2018 |
Clinical next‐generation sequencing in patients with non–small cell lung cancer IS Hagemann, S Devarakonda, CM Lockwood, DH Spencer, K Guebert, ... Cancer 121 (4), 631-639, 2015 | 234 | 2015 |
Non–small-cell lung cancer with brain metastasis at presentation SN Waqar, PP Samson, CG Robinson, J Bradley, S Devarakonda, L Du, ... Clinical lung cancer 19 (4), e373-e379, 2018 | 209 | 2018 |
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer AH Wagner, S Devarakonda, ZL Skidmore, K Krysiak, A Ramu, L Trani, ... Nature communications 9 (1), 3787, 2018 | 143 | 2018 |
Adjuvant chemotherapy for patients with T2N0M0 NSCLC D Morgensztern, L Du, SN Waqar, A Patel, P Samson, S Devarakonda, ... Journal of Thoracic Oncology 11 (10), 1729-1735, 2016 | 99 | 2016 |
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer KC Cotto, YY Feng, A Ramu, M Richters, SL Freshour, ZL Skidmore, H Xia, ... Nature communications 14 (1), 1589, 2023 | 78 | 2023 |
Genomic profiling of lung adenocarcinoma in never-smokers S Devarakonda, Y Li, F Martins Rodrigues, S Sankararaman, H Kadara, ... Journal of Clinical Oncology 39 (33), 3747-3758, 2021 | 78 | 2021 |
Overcoming chemotherapy resistance in SCLC BH Herzog, S Devarakonda, R Govindan Journal of Thoracic Oncology 16 (12), 2002-2015, 2021 | 73 | 2021 |
Circulating tumor DNA profiling in small-cell lung cancer identifies potentially targetable alterations S Devarakonda, S Sankararaman, BH Herzog, KA Gold, SN Waqar, ... Clinical Cancer Research 25 (20), 6119-6126, 2019 | 50 | 2019 |
Genomics of squamous cell lung cancer M Rooney, S Devarakonda, R Govindan The oncologist 18 (6), 707-716, 2013 | 43 | 2013 |
Review of ongoing clinical trials in non–small-cell lung cancer: a status report for 2012 from the ClinicalTrials. gov web site J Subramanian, T Regenbogen, G Nagaraj, A Lane, S Devarakonda, ... Journal of Thoracic Oncology 8 (7), 860-865, 2013 | 42 | 2013 |
Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway J Carrot-Zhang, X Yao, S Devarakonda, A Deshpande, JS Damrauer, ... Cell reports 34 (5), 2021 | 37 | 2021 |
Bone metastases in non-small cell lung cancer: a narrative review BJ Knapp, S Devarakonda, R Govindan Journal of Thoracic Disease 14 (5), 1696, 2022 | 35 | 2022 |
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer GR Blumenschein, S Devarakonda, M Johnson, V Moreno, J Gainor, ... Journal for immunotherapy of cancer 10 (1), e003581, 2022 | 35 | 2022 |
A phase I trial of sunitinib and rapamycin in patients with advanced non-small cell lung cancer SN Waqar, PK Gopalan, K Williams, S Devarakonda, R Govindan Chemotherapy 59 (1), 8-13, 2013 | 30 | 2013 |
Early mortality in patients undergoing adjuvant chemotherapy for non–small cell lung cancer D Morgensztern, PS Samson, SN Waqar, S Devarakonda, CG Robinson, ... Journal of Thoracic Oncology 13 (4), 543-549, 2018 | 26 | 2018 |
Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinoma S Devarakonda, D Morgensztern, R Govindan Oncology 27 (9), 899, 2013 | 22 | 2013 |
Trends in stage I lung cancer A Singareddy, ME Flanagan, PP Samson, SN Waqar, S Devarakonda, ... Clinical Lung Cancer 24 (2), 114-119, 2023 | 19 | 2023 |